IN8bio

(NASDAQ) INAB

Current Price$1.45

Market Cap$14.28M

Since IPO (2021)-100%

5 YearN/A

1 Year-60%

1 Month-8%

IN8bio Financials at a Glance

Market Cap

$14.28M

Revenue (TTM)

$0.00

Net Income (TTM)

-$18.98M

EPS (TTM)

-$2.85

P/E Ratio

-0.51

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.45

Volume

72,969

Open

$1.56

Price

$1.45

Volume

72,969

Open

$1.56

Previous Close

$1.45

Daily Range

$1.43 - $1.57

52-Week Range

$1.17 - $3.66

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.45

Volume

72,969

Open

$1.56

Previous Close

$1.45

Daily Range

$1.43 - $1.57

52-Week Range

$1.17 - $3.66

Estimated Earnings Date

Aug 6, 2026

INAB News

IN8bio (INAB) Q2 Loss Narrows 77%

Motley Fool Markets TeamAug 7, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About IN8bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

William T. Ho, MBA

Website

www.in8bio.com

Headquarters

New York City, NY 10118, US

INAB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-104%

Return on Capital

-79%

Return on Assets

-72%

Earnings Yield

-1.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.28M

Shares Outstanding

9.85M

Volume

72.97K

Avg. Volume

72.44K

Financials (TTM)

Gross Profit

-$2.50M

Operating Income

-$19.86M

EBITDA

-$17.36M

Operating Cash Flow

-$12.71M

Capital Expenditure

$0.00

Free Cash Flow

-$12.71M

Cash & ST Invst.

$27.09M

Total Debt

$2.78M

IN8bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$500.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$14.28M

N/A

Market Cap/Employee

$793.24K

N/A

Employees

N/A

Net Income

-$5.09M

+8.3%

EBITDA

-$4.77M

+4.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$19.59M

+157.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.33M

-56.3%

Short Term Debt

$1.03M

-16.9%

Return on Assets

-72.26%

N/A

Return on Invested Capital

-79.46%

N/A

Free Cash Flow

-$4.96M

-58.7%

Operating Cash Flow

-$4.95M

-58.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PHIOPhio Pharmaceuticals Corp.

PHIOPhio Pharmaceuticals Corp.$1.06-7.02%

KPRXKiora Pharmaceuticals, Inc.

KPRXKiora Pharmaceuticals, Inc.$2.50-4.94%

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.72-5.41%

BCDABioCardia, Inc.

BCDABioCardia, Inc.$1.03+12.08%

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$5.60-4.11%

APREAprea Therapeutics, Inc.

APREAprea Therapeutics, Inc.$0.74-4.37%

HCWBHCW Biologics Inc.

HCWBHCW Biologics Inc.$1.63+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

MRVLMarvell Technology

MRVLMarvell Technology$263.47-0.17%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About INAB

What is the current price of IN8bio?

IN8bio is trading at $1.45 per share.

What is the 52-week range for IN8bio?

Over the past 52 weeks, IN8bio has traded between $1.17 and $3.66.

How much debt does IN8bio have?

As of the most recent reporting period, IN8bio reported total debt of $2.35M.

How much cash does IN8bio have on hand?

IN8bio reported $21.94M in cash and cash equivalents in its most recent financial results.

What is IN8bio’s dividend yield?

IN8bio does not currently have a dividend yield.

IN8bio

IN8bio Financials at a Glance

INAB News

IN8bio (INAB) Q2 Loss Narrows 77%

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About IN8bio

INAB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

IN8bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INAB

What is the current price of IN8bio?

What is the 52-week range for IN8bio?

How much debt does IN8bio have?

How much cash does IN8bio have on hand?

What is IN8bio’s dividend yield?

Premium Investing Services